Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-005732
Filing Date
2025-04-22
Accepted
2025-04-22 17:24:24
Documents
9

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 344762
2 ex5-1.htm EX-5.1 13220
3 ex10-1.htm EX-10.1 51374
4 ex23-2.htm EX-23.2 3794
5 ex107.htm EX-FILING FEES 14840
6 ex5-1_001.jpg GRAPHIC 33606
7 ex5-1_002.jpg GRAPHIC 30201
8 forms-3_001.jpg GRAPHIC 6160
9 forms-3_002.jpg GRAPHIC 12487
  Complete submission text file 0001641172-25-005732.txt   543150
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286684 | Film No.: 25858623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)